Axis Midcap Mutual Fund Review: Worthy Choice Over Market Cycles

BASIC FACTS

RELEASE DATE

FEBRUARY 18, 2011

CATEGORY

CAPITAL

TYPE

MEDIUM CAPITALIZATION

AUM*

17,645 crores

REFERENCE POINT

S&P BSE 150 MIDCAP

TOTAL RETURN INDEX

WHAT IT COST

NAV**

GROWTH OPTION

Rs 64.32

IDCW

Rs 31.41

MINIMUM INVESTMENT

5,000 rupees

MINIMUM AMOUNT OF SIP

500 rupees

EXPENDITURE RATE*** (%)

1.63

EXIT LOAD

For units that exceed 10% of the investment, 1% will be charged for reimbursement within 365 days.

*AS OF MARCH 31, 2022
**AS OF MAY 4, 2022
***AS OF MARCH 31, 2022

FUND MANAGER

SHREYASH DEVALKAR

TERM: 5 YEARS, 5 MONTHS

Recent portfolio changes
New entries

Gujarat Fluorochemicals, TVS Motor Company, Vedant Fashions, Fortis Healthcare, Linde India, Oberoi Realty.


Complete Exits

Tata Consumer Products, FSN E-Commerce Ventures, Indiamart Intermesh, Indigo Paints, Medplus Health Services.

Should you buy?

This mid-cap fund maintains a strong presence in large-cap funds unlike many peers. This is due to the strict emphasis on quality in the fund manager’s stock selection approach. Their preference is for companies that have a leadership position within a niche area or are challenging larger rivals on a larger stage. The size of the portfolio has expanded from 35-40 stocks two years ago to around 60 as more companies began to participate in rising earnings amid the economic recovery. Due to its distinctive style, the fund boasts a vastly outperformance on the downside, but tends to underperform in momentum-driven markets such as in 2021. It remains a valuable choice in full market cycles.

(Source: value research)